Third Joint Workshop on AMR in Salmonella and Campylobacter
This workshop on AMR in Salmonella and Campylobacter was arranged in cooperation with the FWD Network and the EU reference laboratory for antimicrobial resistance network.
Antimicrobial resistance remains commonly detected in bacteria in humans, animals and food: EFSA-ECDC report
Bacteria such as Salmonella and Campylobacter, some of the most common causes of food-borne infections, showed significant resistance to common antimicrobials, according to the newly published EFSA-ECDC European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2012.
Antimicrobial resistance remains high – says EU report
The findings in the latest report on antimicrobial resistance (AMR) in bacteria from ECDC and EFSA underline the serious threat AMR poses to public and animal health. Infections caused by bacteria that are resistant to antimicrobials lead to about 25 000 deaths in the EU every year.
Salmonella and Campylobacter show significant levels of resistance to common antimicrobials in humans and animals
Treatment options for some of the most common food-borne infections are decreasing, as types of bacteria (called ‘isolates’) continue to show resistance to antimicrobial drugs.
EFSA and ECDC publish first joint report on antimicrobial resistance in zoonotic bacteria affecting humans, animals and foodArchived
The report indicates that resistance to antimicrobials was observed in zoonotic bacteria, such as Salmonella and Campylobacter, which may cause infectious diseases transmissible between animals and humans and which can be found in foods.
Antimicrobial resistance in zoonotic bacteria still high in humans, animals and food, say ECDC and EFSA
Bacteria from humans and animals continue to show resistance to antimicrobials, according to a new report published today by the European Food Safety Authority and the European Centre for Disease Prevention and Control. The report highlights some emerging issues and confirms antimicrobial resistance as one of the biggest threats to public health. AMR reduces the effectiveness of treatment options.